Recent advances in the understanding of the peritoneal membrane

2024-9-18

Social and humanitarian issues in nephrology and hypertension

2024-9-11

The role of international renal disaster preparedness working groups in difficult settings: bridge over troubled water

2024-9-5

Justifying access to kidney care in low resource and humanitarian settings

2024-9-3

Do not forget about transplant patients during disasters

2024-9-2

Serum creatinine and serum cystatin C as an index of muscle mass in adults

2024-8-20

HIV-associated kidney disease: the changing spectrum and treatment priorities

2024-8-20

Optimizing kidney and cardiovascular protection in an era of multiple effective treatments

2024-8-14

The impact of chronic kidney disease on cognitive function

2024-8-13

Screening for chronic kidney disease: change of perspective and novel developments

2024-8-13

Plant-based diets for kidney disease prevention and treatment

2024-8-7

Editorial introductions

2024-8-1

Disaster preparedness for people with kidney disease and kidney healthcare providers

2024-7-24

Quality of life in people with chronic kidney disease: focusing on modifiable risk factors

2024-7-23

Synergistic susceptibility to environmental lead toxicity in chronic kidney disease

2024-7-17

Vasopressin, protein metabolism, and water conservation

2024-6-27

Postnatal renal tubule development: roles of tubular flow and flux

2024-6-24

Assessment of the response to kidney patients’ needs in disaster-stricken Syria

2024-6-20

Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease

2024-6-19

Aldosterone-independent regulation of K+ secretion in the distal nephron

2024-6-18

Centering marginalized voices in advocacy for equitable policy change in kidney disease

2024-6-17

Editorial introductions

2024-5-30

Antineutrophil cytoplasmic antibody-associated vasculitis

2024-5-24

The role of claudins in renal transepithelial transport and kidney disease

2024-5-10

Revisiting resistant hypertension in kidney disease

2024-5-10

Cancer drugs and acute kidney injury: new therapies and new challenges

2024-5-7

Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays

2024-5-3

Women's health and kidney protective medications

2024-5-3

New insights into renal calcium-sensing receptor activation

2024-5-1

Fibroblast growth factor 23 is pumping iron: C-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism

2024-4-26

Integrating the patient voice: patient-centred and equitable clinical risk prediction for kidney health and disease

2024-4-24

Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease

2024-4-23

Lysine and salt-sensitive hypertension

2024-4-19

Thiazides for kidney stone recurrence prevention

2024-4-12

A molecular journey on the pathogenesis of primary hyperoxaluria

2024-4-11

The role of hypoxia in chronic kidney disease: a nuanced perspective

2024-4-10

New tools to study renal fibrogenesis

2024-4-8

New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease

2024-4-4

Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism

2024-4-4

Phosphate sensing in health and disease

2024-4-2

Editorial introductions

2024-3-26

Alport syndrome and Alport kidney diseases – elucidating the disease spectrum

2024-3-14

APOL1 nephropathy – a population genetics success story

2024-2-29

Prediction models for earlier stages of chronic kidney disease

2024-2-29

A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?

2024-2-29

Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?

2024-2-23

Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression

2024-2-23

Cystatin C should be routinely available for estimating kidney function

2024-2-23

New therapies for immunoglobulin A nephropathy: what's the standard of care in 2023?

2024-2-23

Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection

2024-2-22